S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT00124579 · TERMINATED
Trial details
- NCT number
- NCT00124579
- Sponsor
- SWOG Cancer Research Network
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2008-06-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.